Ozempic Face Pushes Gen X Toward Facelifts Early
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Stock picking may pay off in certain market conditions and for investors with time and expertise. Learn factors to consider before deviating from index funds.
26,454 articlesGen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
A couple nearing retirement with $1.6 million in pre-tax 401K assets weighs a Roth conversion path to reduce taxes an...
What if the way we speak about money matters as much as the numbers we report? This finance-focused piece uses Christ...
In 2026, investors are focusing on profits, not just sales. This guide explains the walmart metric watch 2026 framewo...
Ibotta's Q1 2026 earnings reveal a company balancing rapid user growth with a longer road to sustainable profitabilit...
RLJ Lodging Trust has fallen about 8% over the last 12 months. Yet a sizeable stake by a key investor suggests there ...
Dell Technologies slid sharply on a broader AI rotation, yet fundamentals remained solid, prompting Jim Cramer to cal...
Salesforce is set to release Q1 results as investors look for evidence that its AI strategy can rekindle growth. A re...
SpaceX stock SPCX rebounds after a three-day selloff, with traders awaiting new catalysts as analysts weigh long-term...
A longtime dividend grower is resurfacing in the spotlight after a 25% price pullback. With a higher-than-Treasury yi...
Raymond James raises Marathon's target to 270, driven by sustained refining margins and strong MPLX distributions. MP...
A global memory crunch has propelled Micron to the forefront of AI-era investing. This article breaks down the why, w...